Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Caris Life Sciences
MedTech
Caris Life Sciences to go public in $400M Nasdaq IPO
Caris recently began rolling out its MI Cancer Seek companion diagnostic test for genomic tumor profiling.
Conor Hale
Jun 9, 2025 10:30am
Caris Life Sciences collects $168M to fund tumor test rollouts
Apr 9, 2025 11:51am
FDA approves Caris multi-cancer companion diagnostic test
Nov 13, 2024 9:00am
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Apr 4, 2024 8:25am
JPM24: Caris crafts collabs with AbbVie, Flatiron Health
Jan 9, 2024 3:34pm
Caris Life Sciences nears $2B in total funding with $400M haul
Jan 19, 2023 4:15pm